FABP4 and metastatic malignant neoplasm in the lymph nodes: Increased FABP4 expression is associated with worse OS and lymph node metastasis, which may be a potential and promising biomarker to assess lymph node status and survival, and may also be a new therapeutic target for patients with node-positive cervical cancer [34, 35].